Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 40.27% is 12% above its 5-year average of 35.94%, near the high end of its 5-year range (32.48%–41.75%).
As of the fiscal period ended Wednesday, December 31, 2025. 8.63% above its 12-month average of 37.07%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
40.27%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
37.07%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
34.89%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
35.94%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
31.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
27.20%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
25.26%
CURRENT VS TTM AVG
+8.63%
CURRENT VS 3Y AVG
+15.43%
CURRENT VS 5Y AVG
+12.06%
CURRENT VS 10Y AVG
+29.88%
CURRENT VS 15Y AVG
+48.05%
CURRENT VS 20Y AVG
+59.44%
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+372.10%
vs the sector median at left
IDEXX Laboratories, Inc.
Market Cap
$42.94B
Return on Invested Capital (ROIC)
40.27%
TTM Avg
37.07%
3Y Avg
34.89%
5Y Avg
35.94%
Market Cap
$39.14B
Return on Invested Capital (ROIC)
12.57%
TTM Avg
12.57%
3Y Avg
13.57%
5Y Avg
12.73%
Market Cap
$46.74B
Return on Invested Capital (ROIC)
3.12%
TTM Avg
3.25%
3Y Avg
5.37%
5Y Avg
7.01%
Market Cap
$47.58B
Return on Invested Capital (ROIC)
11.40%
TTM Avg
11.07%
3Y Avg
14.43%
5Y Avg
15.83%
Market Cap
$36.28B
Return on Invested Capital (ROIC)
13.74%
TTM Avg
4.84%
3Y Avg
-6.97%
5Y Avg
-13.43%
Market Cap
$34.72B
Return on Invested Capital (ROIC)
8.23%
TTM Avg
8.41%
3Y Avg
8.23%
5Y Avg
6.99%
Market Cap
$32.77B
Return on Invested Capital (ROIC)
5.69%
TTM Avg
6.03%
3Y Avg
3.95%
5Y Avg
3.95%
Market Cap
$53.41B
Return on Invested Capital (ROIC)
11.37%
TTM Avg
10.09%
3Y Avg
4.86%
5Y Avg
-0.22%
Market Cap
$31.59B
Return on Invested Capital (ROIC)
21.54%
TTM Avg
21.87%
3Y Avg
20.30%
5Y Avg
19.27%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IDEXX Laboratories, Inc. (IDXX) | $42.94B | 40.27% | 37.07% | 34.89% | 35.94% |
| Agilent Technologies, Inc. (A)vs › | $39.14B | 12.57% | 12.57% | 13.57% | 12.73% |
| Humana Inc. (HUM)vs › | $46.74B | 3.12% | 3.25% | 5.37% | 7.01% |
| Edwards Lifesciences Corporation (EW)vs › | $47.58B | 11.40% | 11.07% | 14.43% | 15.83% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $36.28B | 13.74% | 4.84% | -6.97% | -13.43% |
| IQVIA Holdings Inc. (IQV)vs › | $34.72B | 8.23% | 8.41% | 8.23% | 6.99% |
| Medline Inc. (MDLN)vs › | $32.77B | 5.69% | 6.03% | 3.95% | 3.95% |
| Cardinal Health, Inc. (CAH)vs › | $53.41B | 11.37% | 10.09% | 4.86% | -0.22% |
| Zoetis Inc. (ZTS)vs › | $31.59B | 21.54% | 21.87% | 20.30% | 19.27% |
| Centene Corp. (CNC)vs › | $31.31B | -13.41% | -4.17% | -0.53% | 0.76% |
ROIC
40.3%
ROE
70.4%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 40.27% |
| 2024-12-31 | 33.87% |
| 2023-12-31 | 32.93% |
| 2022-12-31 | 32.48% |
| 2021-12-31 | 41.75% |
| 2020-12-31 | 34.32% |
| 2019-12-31 | 32.09% |
| 2018-12-31 | 34.71% |
| 2017-12-31 | 20.92% |
| 2016-12-31 | 20.02% |
| 2015-12-31 | 17.71% |
| 2014-12-31 | 17.27% |
| 2013-12-31 | 18.47% |
| 2012-12-31 | 19.73% |
| 2011-12-31 | 19.45% |
| 2010-12-31 | 19.21% |
| 2009-12-31 | 18.34% |
| 2008-12-31 | 18.94% |
| 2007-12-31 | 17.21% |
| 2006-12-31 | 21.01% |
| 2005-12-31 | 19.69% |
| 2004-12-31 | 18.24% |
| 2003-12-31 | 13.04% |
| 2002-12-31 | 12.70% |
| 2001-12-31 | 11.67% |
| 2000-12-31 | 12.39% |
| 1999-12-31 | 10.06% |
| 1998-12-31 | 9.17% |
| 1997-12-31 | -0.94% |
| 1996-12-31 | 8.50% |
